{"id":24598,"date":"2017-01-27T10:48:54","date_gmt":"2017-01-27T09:48:54","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=24598"},"modified":"2017-01-27T10:48:54","modified_gmt":"2017-01-27T09:48:54","slug":"entrevista-ramon-bonet-vocal-de-dindustria-del-cofb","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2017\/01\/27\/entrevista-ramon-bonet-vocal-de-dindustria-del-cofb\/","title":{"rendered":"Entrevista a Ramon Bonet, vocal d’Ind\u00fastria del COFB"},"content":{"rendered":"

Ramon Bonet, vocal d’Ind\u00fastria del Col\u00b7legi<\/strong>, explica al primer n\u00famero de la revista Industria Farmac\u00e9utica y Cosm\u00e9tica<\/strong><\/a><\/em> del grup editorial Intermepresas\u00a0la situaci\u00f3 actual del sector de la ind\u00fastria farmac\u00e8utica. Recuperem l’entrevista que podeu llegir \u00edntegra a continuaci\u00f3:<\/p>\n

Entrevista publicada\u00a0al primer n\u00famero de la revista\u00a0Industria Farmac\u00e9utica y Cosm\u00e9tica<\/em>\u00a0del grup editorial Intermepresas<\/strong>.
\nEntrevista la periodista M\u00f3nica Daluz<\/strong>.<\/div>\n

El representant del Col\u00b7legi de Farmac\u00e8utics de Barcelona ens posa al dia sobre el panorama del sector farmac\u00e8utic. Una ind\u00fastria compromesa amb el sistema sanitari, en un escenari marcat per la irrupci\u00f3 dels medicaments biotecnol\u00f2gics, l’expiraci\u00f3 de patents i la propera implantaci\u00f3 de la identificaci\u00f3 unit\u00e0ria dels medicaments. Bonet aborda en aquesta xerrada les vicissituds del sector des dels \u00e0mbits de la recerca, el mercat i la societat.<\/strong><\/p>\n

Podria descriure sint\u00e8ticament el proc\u00e9s de transformaci\u00f3 del sector farmac\u00e8utic en els \u00faltims anys?<\/strong><\/p>\n

Est \u00e9s un sector complex, i amb diversos fronts oberts. Hem viscut uns anys molt marcats per la contenci\u00f3 de la despesa farmac\u00e8utica i per la generificaci\u00f3 de la majoria de les nostres mol\u00e8cules. El sector ha experimentat una reconversi\u00f3 fruit de la necessitat de fer sostenible el sistema sanitari i perqu\u00e8 ha vist expirar el per\u00edode de patents de la majoria de medicaments que estava comercialitzant.<\/p>\n

\"ramon-bonet-vocal-industria-cofb\"<\/a>
Ramon Bonet, vocal d’Ind\u00fastria del COFB<\/figcaption><\/figure>\n

Com ho ha compensat la ind\u00fastria?<\/strong><\/p>\n

Ha seguit reinvertint en recerca; una aposta que actualment s’enfoca, cada vegada m\u00e9s, cap als medicaments biotecnol\u00f2gics. Es tracta d’una recerca m\u00e9s cara i m\u00e9s lenta per\u00f2 ara estem comen\u00e7ant a recollir els fruits de tot aix\u00f2. Ha arribat un moment en el qual la caiguda de patents i la situaci\u00f3 del mercat estan m\u00e9s o menys estabilitzades.<\/p>\n

Hi ha hagut una estrat\u00e8gia d’ampliaci\u00f3 de portafoli?<\/strong><\/p>\n

En efecte, ara estan comen\u00e7ant a apar\u00e8ixer medicaments amb els quals enriquir els portafolis. A m\u00e9s, la majoria de les ind\u00fastries el que han fet ha estat diversificar a l’\u00e0rea de parafarm\u00e0cia, convertint-nos, ja no tant en empreses que venen medicaments, sin\u00f3 en empreses que es fan responsables de l’abordatge de la malaltia; estem contribuint, a m\u00e9s d’amb el medicament en si mateix, amb altres eines que ajuden al pacient a tenir una millor qualitat de vida i a controlar millor la malaltia.<\/p>\n

Les coses han canviat en mat\u00e8ria de promoci\u00f3 de producte\u2026 qui \u00e9s, ara com ara, el vostre interlocutor?<\/strong><\/p>\n

S\u00ed, abans, quan llan\u00e7aves un medicament, la promoci\u00f3 era a trav\u00e9s del metge; en els \u00faltims temps el decisor s’ha despla\u00e7at del metge al gestor d’aquesta medicaci\u00f3, en el nostre cas, a Espanya, les comunitats aut\u00f2nomes que s\u00f3n, al final, les que financen.<\/p>\n

\u00a0\u201cLa ind\u00fastria s’ha convertit en un suport a la gesti\u00f3 integral del sistema sanitari p\u00fablic<\/p><\/blockquote>\n

\u2026 I aix\u00f2 implica\u2026<\/strong><\/p>\n

Que has de buscar noves maneres de gesti\u00f3 d’acc\u00e9s al mercat; des de contractes de risc compartit on el preu va vinculat a l’efic\u00e0cia del producte, o b\u00e9 a trav\u00e9s del model en el qual no es pacta preu per unitat venuda sin\u00f3 que s’acorda un preu per resultats obtinguts en funci\u00f3 de l’estalvi que el medicament genera al sistema. La manera en qu\u00e8 s’aborda una patologia est\u00e0 cada vegada m\u00e9s marcada pels gestors de l’administraci\u00f3. Cada vegada es tendeix m\u00e9s a pagar per estalvi al sistema que pel cost del producte en si mateix.<\/p>\n

Posi algun exemple.<\/strong><\/p>\n

El cas del tractament de l’hepatitis C. \u00c9s una malaltia cr\u00f2nica, per tant ten\u00edem un pacient cr\u00f2nic, amb un cost molt alt per al sistema sanitari. Si el per\u00edode de tractament pot resultar molt car, l’estalvi total pel que fa al que aquest pacient consumia durant el seu cicle de vida, compensa. Aquest \u00e9s el tipus de plantejament amb el qual la ind\u00fastria i la sanitat estan abordant la gesti\u00f3 de les malalties: s’ha passat d’aquell concepte de tenir un medicament per a una patologia -anaves al metge, ho promocionaves i ho venies-, a parlar d’un concepte de gesti\u00f3 integral del sistema sanitari, i la ind\u00fastria s’ha convertit en un suport a la gesti\u00f3 integral del sistema sanitari p\u00fablic.<\/p>\n

\"industria-farmaceutica\"<\/a><\/p>\n

L’oficina de farm\u00e0cia s’ha vist desbordada en els \u00faltims anys per les obligacions burocr\u00e0tiques i administratives venint a reduir el paper del farmac\u00e8utic com a sanitari. Quina \u00e9s la tend\u00e8ncia en aquest sentit?<\/strong><\/p>\n

La farm\u00e0cia est\u00e0 contemplada com un element clau en qualsevol tipus de medicament, excepte en els hospitalaris, per\u00f2 en el gruix de medicaments la farm\u00e0cia juga un paper clau de recomanaci\u00f3 i indicaci\u00f3 d’\u00fas perqu\u00e8 \u00e9s la que est\u00e0 m\u00e9s prop del pacient. Especialment important en aquells medicaments que no requereixen recepta, i que per tant estan subjectes a la indicaci\u00f3 del farmac\u00e8utic. Quan es tracta d’un producte amb recepta m\u00e8dica, el farmac\u00e8utic contribueix al seguiment farmacoterap\u00e8utic, a que el medicament s’utilitzi amb la pauta donada.Tens l’exemple en l’SPD, Sistema Personalitzat de Dosificaci\u00f3, que pret\u00e9n garantir els resultats, que el medicament sigui efectiu, i tant a la ind\u00fastria com a l’Administraci\u00f3 els interessa que el pacient ho prengui adequadament; en cas contrari aquest estar\u00e0 menys controlat, la ind\u00fastria veur\u00e0 redu\u00efts els resultats i l’efic\u00e0cia del medicament, i l’Administraci\u00f3 estar\u00e0 incorrent en uns costos innecessaris; dins d’aquest engranatge, el paper de la farm\u00e0cia \u00e9s clau.<\/p>\n

Mentrestant, davant de nosaltres una societat cada vegada m\u00e9s envellida\u2026<\/strong><\/p>\n

S\u00ed, ser\u00e0 una societat de pacient cr\u00f2nic, complex i polimedicat. Pensa en una persona major que ha de prendre tres o quatre medicaments di\u00e0riament en diferents moments del dia, m\u00e9s els propis de l’edat\u2026, amb l’SPD contribu\u00efm al fet que es faci aquest seguiment farmacoterap\u00e8utic. En qualsevol cas, el farmac\u00e8utic t\u00e9 un rol cent per cent sanitari, i mentre que sanitari, des de la farm\u00e0cia es permet aquest abordatge global: el metge far\u00e0 una prescripci\u00f3 m\u00e8dica i el farmac\u00e8utic, basant-se en aquesta recepta i en els seus coneixements \u00e9s capa\u00e7 de, amb tot el ventall de parafarm\u00e0cia, recomanar i ajudar al pacient a portar millor la seva malaltia.<\/p>\n

A l’oficina de farm\u00e0cia se li obren noves oportunitats amb els nous medicaments biol\u00f2gics, la incorporaci\u00f3 de productes de cosm\u00e8tica, parafarm\u00e0cia, complements nutricionals. Est\u00e0 la farm\u00e0cia gestionant adequadament aquest mix?<\/strong><\/p>\n

La farm\u00e0cia \u00e9s un centre integral de salut i, per tant, t\u00e9 l’opci\u00f3 del medicament com a tal o tot un arsenal de \u2018no medicament\u2019. La ind\u00fastria, cada vegada m\u00e9s, el que est\u00e0 fent \u00e9s col\u00b7laborar amb el farmac\u00e8utic en aquest abordatge integral; t\u00e9 els seus portafolis diversificats de manera que si, per exemple, una companyia farmac\u00e8utica treballa la diabetis, t\u00e9 associades l\u00ednies de cosm\u00e8tica espec\u00edfiques o altres productes que no s\u00f3n medicaments en si per\u00f2 que ajuden. T\u00e9 lloc una interacci\u00f3 amb el farmac\u00e8utic per recolzar-li en la venda i guiar-li en la indicaci\u00f3, amb l’objectiu de que el pacient millori la seva patologia i la seva qualitat de vida.<\/p>\n

\"Mortar<\/a><\/strong><\/p>\n

Es parla de recuperar el paper del farmac\u00e8utic com a formulador, com es contempla la formulaci\u00f3 fora de l’\u00e0mbit de la ind\u00fastria?<\/strong><\/p>\n

Es tracta d’un sistema complementari. Existeixen determinades situacions, com a ajustaments de dosis en pacients pedi\u00e0trics, determinats processos en els quals no hi ha una f\u00f3rmula adequada per a una determinada patologia i segurament no seria rendible fabricar-la industrialment pel volum de casos, o per un problema de mercat, per falta de determinat producte; aqu\u00ed el farmac\u00e8utic esdev\u00e9 clau. La formulaci\u00f3 magistral sempre ha estat recolzada per la ind\u00fastria; ambdues compleixen dues necessitats sanit\u00e0ries diferents i complement\u00e0ries.<\/p>\n

Parli’ns dels nous models de negoci basats en la cooperaci\u00f3 que s’han gestat entorn dels desenvolupaments biotecnol\u00f2gics.<\/strong><\/p>\n

La biotecnologia ha crescut en bona part gr\u00e0cies a petites empreses i petits centres de recerca que han arribat a desenvolupar un medicament espec\u00edfic, o s\u00f3n forts en una determinada l\u00ednia de recerca. El que s’ha fet han estat aliances entre la ind\u00fastria farmac\u00e8utica, que t\u00e9 tots els recursos de comercialitzaci\u00f3 (acc\u00e9s al mercat, for\u00e7a de vendes, equips de market acces<\/em>), i aquestes empreses, que tenen els recursos de recerca. Es d\u00f3na una situaci\u00f3 ideal on s’uneixen les dues voluntats: una pot\u00e8ncia investigadora forta interna i externa, i la capacitat d’acc\u00e9s al mercat.<\/p>\n

Un mercat molt m\u00e9s segmentat<\/strong><\/p>\n

El nombre de pacients ja no ser\u00e0 de milions; no es donar\u00e0 la situaci\u00f3 d’un altre temps en qu\u00e8 es realitzava la troballa d’un medicament del que es venien milions d’unitats. Ara la tend\u00e8ncia \u00e9s cap a una medicaci\u00f3 que tracta de manera m\u00e9s personalitzada. Ning\u00fa est\u00e0 pensant en medicaments massius sin\u00f3 en efic\u00e0cies.<\/p>\n

I per acabar, ens pot parlar de la lluita contra les falsificacions i del proc\u00e9s d’implantaci\u00f3 de la serialitzaci\u00f3 dels medicaments?<\/strong><\/p>\n

La globalitzaci\u00f3 ha portat amb si que el flux internacional de medicaments sigui cada vegada m\u00e9s alt i aix\u00f2 obre la porta a potencials falsificacions. Securitzar els fluxos dels medicaments \u00e9s una obsessi\u00f3 de tots en el nostre sector i, des d’ara i fins a 2019, veurem la serialitzaci\u00f3 dels medicaments amb identificaci\u00f3 unit\u00e0ria de totes i cadascuna de les caixes, de manera que abans que un farmac\u00e8utic dispensi una caixa haur\u00e0 de verificar que el producte \u00e9s aut\u00e8ntic. En aquests moments ens trobem en el proc\u00e9s de definir tots els mecanismes de control.<\/p>\n


\nTamb\u00e9 la podeu consultar en format digital al seg\u00fcent enlla\u00e7:\u00a0Entrevista a Ramon Bonet, vocal de Industria del COFB<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"

Ramon Bonet, vocal d’Ind\u00fastria del Col\u00b7legi, explica al primer n\u00famero de la revista Industria Farmac\u00e9utica y Cosm\u00e9tica del grup editorial Intermepresas\u00a0la situaci\u00f3 actual del sector de la ind\u00fastria farmac\u00e8utica. Recuperem l’entrevista que podeu llegir \u00edntegra a continuaci\u00f3: El representant del Col\u00b7legi de Farmac\u00e8utics de Barcelona ens posa al dia sobre […]<\/p>\n","protected":false},"author":1,"featured_media":24615,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[57],"tags":[2156,2412,2630,2149,2631],"class_list":["post-24598","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mon-collegial","tag-industria","tag-industria-farmaceutica","tag-interempresas","tag-publicacions","tag-ramon-bonet"],"yoast_head":"\nEntrevista a Ramon Bonet, vocal d'Ind\u00fastria del COFB<\/title>\n<meta name=\"description\" content=\"Entrevista a Ramon Bonet, vocal d'Ind\u00fastria del COFB (Col\u00b7legi de Farmac\u00e8utics de Barcelona). Revista Industria Farmac\u00e9utica y Cosm\u00e9tica (Intermepresas)\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2017\/01\/27\/entrevista-ramon-bonet-vocal-de-dindustria-del-cofb\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Entrevista a Ramon Bonet, vocal d'Ind\u00fastria del COFB\" \/>\n<meta property=\"og:description\" content=\"Entrevista a Ramon Bonet, vocal d'Ind\u00fastria del COFB (Col\u00b7legi de Farmac\u00e8utics de Barcelona). Revista Industria Farmac\u00e9utica y Cosm\u00e9tica (Intermepresas)\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2017\/01\/27\/entrevista-ramon-bonet-vocal-de-dindustria-del-cofb\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2017-01-27T09:48:54+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/01\/27\/entrevista-ramon-bonet-vocal-de-dindustria-del-cofb\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/01\/27\/entrevista-ramon-bonet-vocal-de-dindustria-del-cofb\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Entrevista a Ramon Bonet, vocal d’Ind\u00fastria del COFB\",\"datePublished\":\"2017-01-27T09:48:54+00:00\",\"dateModified\":\"2017-01-27T09:48:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/01\/27\/entrevista-ramon-bonet-vocal-de-dindustria-del-cofb\/\"},\"wordCount\":1724,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/01\/27\/entrevista-ramon-bonet-vocal-de-dindustria-del-cofb\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"Ind\u00fastria\",\"ind\u00fastria farmac\u00e8utica\",\"Interempresas\",\"Publicacions\",\"Ramon Bonet\"],\"articleSection\":[\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2017\/01\/27\/entrevista-ramon-bonet-vocal-de-dindustria-del-cofb\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/01\/27\/entrevista-ramon-bonet-vocal-de-dindustria-del-cofb\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2017\/01\/27\/entrevista-ramon-bonet-vocal-de-dindustria-del-cofb\/\",\"name\":\"Entrevista a Ramon Bonet, vocal d'Ind\u00fastria del COFB\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/01\/27\/entrevista-ramon-bonet-vocal-de-dindustria-del-cofb\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/01\/27\/entrevista-ramon-bonet-vocal-de-dindustria-del-cofb\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2017-01-27T09:48:54+00:00\",\"dateModified\":\"2017-01-27T09:48:54+00:00\",\"description\":\"Entrevista a Ramon Bonet, vocal d'Ind\u00fastria del COFB (Col\u00b7legi de Farmac\u00e8utics de Barcelona). Revista Industria Farmac\u00e9utica y Cosm\u00e9tica (Intermepresas)\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/01\/27\/entrevista-ramon-bonet-vocal-de-dindustria-del-cofb\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2017\/01\/27\/entrevista-ramon-bonet-vocal-de-dindustria-del-cofb\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/01\/27\/entrevista-ramon-bonet-vocal-de-dindustria-del-cofb\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/01\/27\/entrevista-ramon-bonet-vocal-de-dindustria-del-cofb\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Entrevista a Ramon Bonet, vocal d’Ind\u00fastria del COFB\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Entrevista a Ramon Bonet, vocal d'Ind\u00fastria del COFB","description":"Entrevista a Ramon Bonet, vocal d'Ind\u00fastria del COFB (Col\u00b7legi de Farmac\u00e8utics de Barcelona). Revista Industria Farmac\u00e9utica y Cosm\u00e9tica (Intermepresas)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2017\/01\/27\/entrevista-ramon-bonet-vocal-de-dindustria-del-cofb\/","og_locale":"ca_ES","og_type":"article","og_title":"Entrevista a Ramon Bonet, vocal d'Ind\u00fastria del COFB","og_description":"Entrevista a Ramon Bonet, vocal d'Ind\u00fastria del COFB (Col\u00b7legi de Farmac\u00e8utics de Barcelona). Revista Industria Farmac\u00e9utica y Cosm\u00e9tica (Intermepresas)","og_url":"https:\/\/novaorg.cofb.net\/2017\/01\/27\/entrevista-ramon-bonet-vocal-de-dindustria-del-cofb\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2017-01-27T09:48:54+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"8 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2017\/01\/27\/entrevista-ramon-bonet-vocal-de-dindustria-del-cofb\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2017\/01\/27\/entrevista-ramon-bonet-vocal-de-dindustria-del-cofb\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Entrevista a Ramon Bonet, vocal d’Ind\u00fastria del COFB","datePublished":"2017-01-27T09:48:54+00:00","dateModified":"2017-01-27T09:48:54+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2017\/01\/27\/entrevista-ramon-bonet-vocal-de-dindustria-del-cofb\/"},"wordCount":1724,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2017\/01\/27\/entrevista-ramon-bonet-vocal-de-dindustria-del-cofb\/#primaryimage"},"thumbnailUrl":"","keywords":["Ind\u00fastria","ind\u00fastria farmac\u00e8utica","Interempresas","Publicacions","Ramon Bonet"],"articleSection":["M\u00f3n col\u00b7legial"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2017\/01\/27\/entrevista-ramon-bonet-vocal-de-dindustria-del-cofb\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2017\/01\/27\/entrevista-ramon-bonet-vocal-de-dindustria-del-cofb\/","url":"https:\/\/novaorg.cofb.net\/2017\/01\/27\/entrevista-ramon-bonet-vocal-de-dindustria-del-cofb\/","name":"Entrevista a Ramon Bonet, vocal d'Ind\u00fastria del COFB","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2017\/01\/27\/entrevista-ramon-bonet-vocal-de-dindustria-del-cofb\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2017\/01\/27\/entrevista-ramon-bonet-vocal-de-dindustria-del-cofb\/#primaryimage"},"thumbnailUrl":"","datePublished":"2017-01-27T09:48:54+00:00","dateModified":"2017-01-27T09:48:54+00:00","description":"Entrevista a Ramon Bonet, vocal d'Ind\u00fastria del COFB (Col\u00b7legi de Farmac\u00e8utics de Barcelona). Revista Industria Farmac\u00e9utica y Cosm\u00e9tica (Intermepresas)","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2017\/01\/27\/entrevista-ramon-bonet-vocal-de-dindustria-del-cofb\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2017\/01\/27\/entrevista-ramon-bonet-vocal-de-dindustria-del-cofb\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/novaorg.cofb.net\/2017\/01\/27\/entrevista-ramon-bonet-vocal-de-dindustria-del-cofb\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2017\/01\/27\/entrevista-ramon-bonet-vocal-de-dindustria-del-cofb\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Entrevista a Ramon Bonet, vocal d’Ind\u00fastria del COFB"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"Ramon Bonet, vocal d’Ind\u00fastria del Col\u00b7legi, explica al primer n\u00famero de la revista Industria Farmac\u00e9utica y Cosm\u00e9tica del grup editorial Intermepresas\u00a0la situaci\u00f3 actual del sector de la ind\u00fastria farmac\u00e8utica. Recuperem l’entrevista que podeu llegir \u00edntegra a continuaci\u00f3: El representant del Col\u00b7legi de Farmac\u00e8utics de Barcelona ens posa al dia sobre […]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/24598","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=24598"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/24598\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=24598"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=24598"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=24598"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}